Ritter Pharmaceuticals (RTTR) Reports Q2 Loss of $0.48/Share

Ritter Pharmaceuticals (NASDAQ: RTTR) reported Q2 EPS of ($0.48), versus ($4.18) reported last year.

For earnings history and earnings-related data on Ritter Pharmaceuticals (RTTR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M